Recombinant factor VIIa use in cardiac surgery - Expanding the arsenal therapy for intractable bleeding?

Journal of Cardiovascular Surgery

Volumn 45, Issue 6, 2004, Pages 569-571

  Kogan, A ^a   Berman, M ^a   Stein, M ^a   Vidne, B A ^a   Raanani, E ^a  

^a RABIN MEDICAL CENTER   (Israel)

Author keywords

Cardiac surgical procedures; Factor VII; Mitral valve; Postoperative hemorrhage; Surgery

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 7; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

AGED; ANAMNESIS; ARTICLE; BACTERIAL ENDOCARDITIS; CARDIOPULMONARY BYPASS; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DISEASE COURSE; HANCOCK VALVE PROSTHESIS; HUMAN; MALE; MEDICAL EXAMINATION; MITRAL VALVE REPLACEMENT; OPERATION DURATION; POSTOPERATIVE HEMORRHAGE; SURGICAL TECHNIQUE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; HEART VALVE REPLACEMENT; MITRAL VALVE; REVIEW;

AGED; ENDOCARDITIS, BACTERIAL; FACTOR VII; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MITRAL VALVE; POSTOPERATIVE HEMORRHAGE; RECOMBINANT PROTEINS;

EID: 15744373805     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Hedner U. Recombinant factor VIIa (NovoSeven®) as a hemostatic agent. Semin Hematol 2001;38 Suppl 12: 43-7.
2. Moscardo F, Perez F, Rubia J, Balerdi B, Lorenzo JI, Senent ML et al. Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. Br J Haematol 2001;113:174-6.
3. Gerlach R, Marquardt G, Wissing H, Scharrer I, Raabe A, Seifert V. Application of recombinant activated factor VII during surgery for a giant skull base hemangiopericytoma to achieve safe hemostasis. J Neurosurg 2002;96:946-8.
4. Martinowitz U, Kenet G, Segal E, Luboshitz J, Lubetsky A, Ingerslev J et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 2001;51:431-8.
5. Al Douri M, Shafi T, Al Khudari D, Al Bokhari E, Black L, Akinwale N et al. Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery. Blood Coagul Fibrinolysis 2000;11 Suppl 1: S121-7.
6. Hendriks HGD, van der Maaten JA, de Wolf J, Waterbolk TW, Slooff MJH, van der Meer J. An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII. Anesth Analg 2001;93:287-9.
7. Zietkiewicz M, Garlicki M, Domagala J, Wierzbinski K, Drwila R, Pfitzner R et al. Successful use of activated recombinant factor VII to control bleeding abnormalities in a patient with left ventricular assist device. J Thorac Cardiovasc Surg 2002;123:384-5.
8. Kastrup M, von Heymann C, Hotz H, Konertz WF, Ziemer S, Kox W et al. Recombinant factor rFVIIa after aortic valve replacement in a patient with osteogenesis imperfecta. Ann Thorac Surg 2002;74:910-2.
9. von Heymann C, Hotz H, Konertz W, Kox WJ, Spies C. Succesfull treatment of refractory bleeding with recombinant factor VIIa after redo coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2002;16:615-6.
10. Bui JD, Despotis GD, Trulock EP, Patterson GA, Goodnough LT. Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had reveived activated recombinant factor VII. J Thorac Cardiovasc Surg 2002;124:852-4.
11. Hall TS, Brevetti GR, Scoultchi AJ, Sines JC, Gregory P, Spotniz AJ. Re-exploration for hemorrhage following open-heart surgery differentiation on the causes of bleeding and the impact on patient outcome. Ann Thorac Cardiovasc Surg 2001;7:352-7.
12. Monroe DM, Hoffman M, Oliver JA, Roberts HR. Platelet activity of high dose factor VIIa is independent of tissue factor. Br J Haematol 1997;99:542-7.